S&P 500

5.303,27

0,12%

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

MSHL

Marshall Edwards (MSHL)

Mei Pharma, Inc. (MM)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MSHL

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
09/07/2012	20h41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
05/07/2012	22h03	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
02/07/2012	21h18	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
28/06/2012	15h00	PR Newswire (US)	Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
06/06/2012	12h04	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
05/06/2012	23h28	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
04/06/2012	15h00	PR Newswire (US)	Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
29/05/2012	15h00	PR Newswire (US)	Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
25/05/2012	19h32	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
15/05/2012	21h27	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
15/05/2012	19h14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
15/05/2012	19h13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
15/05/2012	19h11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
15/05/2012	16h05	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
14/05/2012	15h00	PR Newswire (US)	Marshall Edwards Completes Rights Offering To Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
08/05/2012	15h00	PR Newswire (US)	Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
25/04/2012	15h00	PR Newswire (US)	Marshall Edwards Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
13/04/2012	21h59	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
11/04/2012	20h41	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
10/04/2012	15h00	PR Newswire (US)	Marshall Edwards Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidat...	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
03/04/2012	15h00	PR Newswire (US)	Marshall Edwards Announces Data from Clinical Trial of ME-143 Selected for Presentation at ASCO Annual Meeting	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
30/03/2012	18h34	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
30/03/2012	18h32	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
28/03/2012	15h00	PR Newswire (US)	Marshall Edwards CEO to Present at Needham Healthcare Conference	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
27/03/2012	15h00	PR Newswire (US)	Marshall Edwards Receives Notice of Effectiveness for Rights Offering to Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
27/03/2012	12h02	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
26/03/2012	22h40	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
20/03/2012	13h55	Edgar (US Regulatory)	Securities Registration Statement (S-1/A)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
19/03/2012	14h00	PR Newswire (US)	Marshall Edwards Announces Terms for Rights Offering to Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
07/03/2012	18h17	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)